Contract research trial proves AMALGEROL efficiency in soybean production

The field trial conducted in Lunga, Romania, in 2024, aimed to evaluate the efficacy of AMALGEROL (AM) biostimulant in enhancing the yield and quality of soybean crops. Sponsored by Hechenbichler GmbH and carried out by SynTech Research Agrico SRL, the trial focused on assessing the impact of AMALGEROL compared to an untreated check.

The trial was designed with soybean variety Davis planted at a density of 40 seeds per square meter.

The experimental setup included AMALGEROL at 5 liters per hectare, applied three times, and six replications per treatment, with each plot measuring 20 m².

AMALGEROL improved plant height by approximately 2% and increased chlorophyll content by about 4- 5% compared to untreated plots, improved plant health and photosynthetic efficiency. The yield increase with AMALGEROL compared to the Untreated Check (UTC) was approximately 8.44%, highlighting its potential to enhance soybean productivity. No phytotoxicity symptoms were observed, ensuring the safety of AMALGEROL for agricultural use.

In summary, the results from this field trial highlight the substantial benefits of using AMALGEROL in soybean cultivation. The biostimulant not only enhances plant growth and health but also significantly increases yield without compromising grain quality. These findings position AMALGEROL as a valuable tool for farmers aiming to achieve more productive and sustainable soybean farming practices. The trial's outcomes suggest that integrating AMALGEROL into soybean cultivation could lead to more robust and economically viable agricultural outcomes, ultimately contributing to the advancement of modern farming techniques.